TNAP limits TGF-ß-dependent cardiac and skeletal muscle fibrosis by inactivating SMAD2/3 transcription factors (2019)
Attributed to:
Cell mediated gene therapy for muscular dystrophy: steps towards clinical efficacy.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/655332
Publication URI: http://dx.doi.org/10.1101/655332
Type: Preprint